Inquiry Basket
Loading ......
High mobility group box 1, or HMGB1, ranks among the most abundant non-histone proteins in mammalian nuclei, yet it is better known publicly as a danger signal released when cells are injured. That dual identity is the central puzzle of HMGB1 biology: the same molecule can act as a quiet architectural component of chromatin in the nucleus and as a potent inflammatory mediator in the extracellular space. Most popular accounts emphasize its extracellular career as a damage-associated molecular pattern and its links to inflammation, cancer, and aging. This article takes a complementary view, tracing the protein's intracellular life and the regulated journey that turns a chromatin-binding factor into an alarm. It covers the nuclear functions of HMGB1 as a DNA chaperone and repair partner, its cytoplasmic role as a checkpoint between autophagy and apoptosis, the post-translational modifications and redox states that govern its relocation, and the programmed release pathways that deliver it to the extracellular space. The aim is to give researchers a clear, mechanism-focused reference that does not overlap disease-centered reviews, while pointing to the generic research-grade tools used to study this pleiotropic protein.
HMGB1 is a roughly 25 kilodalton chromatin-associated protein built from two homologous HMG-box domains, an N-terminal A box and a central B box, followed by a long acidic C-terminal tail. Each box folds into three alpha helices arranged in an L-shaped conformation, and together the boxes bind DNA without sequence preference but with high affinity for distorted and non-canonical structures such as bent, kinked, cruciform, or cisplatin-modified DNA. The acidic tail, rich in glutamic and aspartic residues, makes intramolecular contacts that dampen DNA binding and tune how strongly HMGB1 loops and bends the double helix, and it also contributes a transcriptional co-activator function. A structural feature with consequences for its extracellular life is the absence of any conventional secretion signal. HMGB1 belongs to a small family that also includes HMGB2, HMGB3, and HMGB4. The first three are more than 80 percent identical in sequence and are each composed of two HMG boxes plus an acidic tail, whereas HMGB4 lacks the tail and is specific to mammals. Expression patterns differ: HMGB1 is ubiquitous and abundant, HMGB2 concentrates in thymus and testis, and HMGB3 appears mainly in embryonic and hematopoietic tissues. The functional redundancy among these factors is striking, as mice lacking HMGB1 are born but die within a day from defective glucocorticoid-receptor activation. Human HMGB1 spans 215 amino acids, and discrete surface patches have been mapped for binding to Toll-like receptor 4, the receptor for advanced glycation end products, and p53. In its native state the protein can form homodimers and higher oligomers, a quaternary behavior that depends on the extraction method. These structural fundamentals underpin every downstream activity described below.
Figure 1. The structure of HmgB1 protein. (Source: Chikhirzhina E, et al. 2020)
Inside the nucleus, HMGB1 behaves as an architectural factor rather than a sequence-specific regulator. Its most fundamental activity is to bend and flex the double helix, an action that relaxes torsional stress, promotes nucleosome sliding and assembly, and helps the transcription and replication machinery gain access to template DNA. The acidic tail modulates this behavior: when it engages the DNA-binding boxes or histones, it changes how tightly HMGB1 loops and bends DNA, and it also participates in co-activation. At the level of the nucleosome, HMGB1 binds linker DNA near the entry and exit points, interacts with linker histone H1 to facilitate its displacement, and contacts the histone H3 tail, together driving local nucleosome remodeling and opening chromatin for regulatory proteins. With roughly one million molecules per nucleus, averaging about one HMGB1 for every ten to fifteen nucleosomes, the protein is well positioned to influence genome organization globally. By bending DNA and stabilizing loops, it recruits transcription factors, chromatin remodelers, and other nuclear partners, which is why it is commonly described as a DNA chaperone. This architectural role is distinct from that of histones and explains why HMGB1 can be redeployed so flexibly between nuclear, cytoplasmic, and extracellular careers without losing its core identity as a chromatin organizer.
Beyond routine chromatin transactions, HMGB1 is an active participant in genome maintenance. It binds both intact and damaged DNA and, by recruiting repair proteins and chromatin-remodeling factors, facilitates several DNA repair pathways including nucleotide excision repair, base excision repair, mismatch repair, and the handling of double-strand breaks. Its preference for distorted and lesion-bearing structures, such as cisplatinated or chemically modified DNA, positions the protein at sites of damage where it can help load the repair machinery. HMGB1 also supports antigen-receptor diversification during V(D)J recombination, where regulated cleavage and rejoining of lymphocyte DNA depend on a relaxed and accessible chromatin environment. The protein has further been linked to transcription-coupled repair and to the maintenance of telomeric stability. Because many DNA-damaging chemotherapeutics create the very distortions that HMGB1 binds with high affinity, the protein can modulate how damaged DNA is processed in tumor cells, a double-edged contribution in which enhanced repair favors survival while the same molecule can later act as an alarm. These nuclear activities are the reason that efforts to block extracellular HMGB1 signaling must avoid crippling its essential housekeeping roles in chromatin and repair.
The decision of whether HMGB1 leaves the nucleus is written into its post-translational code rather than left to chance. In the resting nucleus, bipartite nuclear localization signals keep the protein bound to importin and retained on chromatin, but cellular stress shifts the balance. Acetylation, carried out by histone acetyltransferases and opposed by deacetylases such as sirtuin 1, neutralizes the basic patches that anchor HMGB1 to DNA and nucleosomes, allowing it to accumulate in the cytoplasm. Phosphorylation, ADP-ribosylation, and methylation of specific lysines add further layers of control over its affinity and location. Equally decisive for what the protein will do once it reaches the outside of the cell is the redox state of three conserved cysteines at positions 23, 45, and 106. In the fully reduced form, with all three thiols free, HMGB1 acts mainly as a chemotactic signal, pairing with the chemokine CXCL12 to engage the CXCR4 receptor and recruit immune cells. When the two cysteines in the A box form an intramolecular disulfide while the third remains reduced, the protein becomes a potent pro-inflammatory stimulus that binds the Toll-like receptor 4 complex through MD-2 and engages the receptor for advanced glycation end products, driving cytokine production through nuclear factor kappa B. Full oxidation of all three cysteines instead yields an inert, even immunosuppressive, form. Nucleus-resident peroxiredoxins help establish the disulfide state before the protein is exported through the CRM1 nuclear export pathway. Because the same molecule's fate and function are set by its modification state, assays that resolve redox isoforms are far more informative than total protein measurements.
Figure 2. HMGB1 in the ccRCC tumor microenvironment as a DAMP. (Source: Alex B. 2025)
Once HMGB1 arrives in the cytoplasm it takes on a survival function that tilts stressed cells toward autophagy and away from apoptosis. The protein binds the autophagy initiator beclin 1 through its cysteine disulfides, displacing the anti-apoptotic protein Bcl-2 and freeing beclin 1 to assemble the class III phosphatidylinositol 3-kinase complex that nucleates autophagosome formation. HMGB1 also shields beclin 1 and the autophagy protein ATG5 from calpain-mediated cleavage, protecting the autophagic machinery from proteolytic shutdown. By favoring autophagic survival, cytoplasmic HMGB1 helps cells cope with DNA damage and other stresses, whereas loss of this checkpoint pushes them toward apoptosis or necrosis. This intracellular role is conceptually distinct from, and can even counterbalance, the extracellular pro-inflammatory role, illustrating how the same molecule exerts opposite effects depending on its location. The beclin 1 interaction depends on the disulfide state established in the previous section, linking redox control directly to the cytoplasmic fate. Researchers studying autophagy therefore need to consider not only where HMGB1 sits but also which redox isoform is present, since the reduced and disulfide forms are not interchangeable in this pathway.
HMGB1 is a textbook example of a protein whose meaning is defined by context. Within the nucleus it is a versatile architectural and repair factor that bends DNA, mobilizes nucleosomes, and assists genome maintenance and immune-receptor diversification. In the cytoplasm it acts as a survival checkpoint that tilts cells toward autophagy and away from apoptosis. Only after regulated export or damage-driven release does it become an extracellular damage-associated molecular pattern whose reduced, disulfide, or oxidized forms dictate whether it attracts immune cells, drives inflammation, or falls silent. Post-translational modifications and the mode of cell death jointly determine this trajectory, making subcellular and redox-resolved measurements far more informative than total protein levels. As a benchmark for studying chromatin dynamics, autophagic defense, and sterile inflammation, HMGB1 will continue to reward approaches that track its location and modification rather than treating it as a single entity. Continued refinement of isoform-defined reagents will help researchers separate its essential housekeeping roles from its alarm functions.
References
| Target | Cat. No. | Product Name | Species | Application | Detection Sample | |
| HMGB1 | DEIABL16 | Pig HMG1/HMGB1 ELISA Kit | Pig | Quantitative | Plasma, Serum | Inquiry |
| DEIA-FB15 | Human HMGB1(High mobility group protein B1) ELISA Kit | Human | Quantitative | Serum, plasma, cell culture supernatant and other biological samples | Inquiry | |
| DEIA-FB16 | Rat Hmgb1(High mobility group protein B1) ELISA Kit | Rat | Quantitative | Serum, plasma, cell culture supernatant and other biological samples | Inquiry | |
| DEIA-FB17 | Mouse Hmgb1(High mobility group protein B1) ELISA Kit | Mouse | Quantitative | Serum, plasma, cell culture supernatant and other biological samples | Inquiry | |
| DEIA-FB18 | Rabbit HMGB-1 (High mobility group protein B1) ELISA Kit | Rabbit | Quantitative | Serum, plasma, tissue homogenates and other biological fluids | Inquiry |
Loading ......
